Evidence map›Paper›PMID 42635196›Full record

ArticleBioinformatics (Oxford, England)2026

miRBind2 enables sequence-only prediction of miRNA binding and transcript repression.

David Čechák, Dimosthenis Tzimotoudis, Stephanie Sammut, Katarina Gresova, Eva Marsalkova, David Farrugia, Panagiotis Alexiou

Abstract read
In one paragraph

Article in Bioinformatics (Oxford, England), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

David ČechákCentral European Institute of Technology, Masaryk University, Brno 625 00, Czech Republic.
Dimosthenis TzimotoudisDepartment of Applied Biomedical Science, Faculty of Health Sciences, University of Malta, Msida, Malta.
Stephanie SammutDepartment of Applied Biomedical Science, Faculty of Health Sciences, University of Malta, Msida, Malta.
Katarina GresovaDepartment of Applied Biomedical Science, Faculty of Health Sciences, University of Malta, Msida, Malta.
Eva MarsalkovaCentral European Institute of Technology, Masaryk University, Brno 625 00, Czech Republic.
David FarrugiaFaculty of ICT, University of Malta, Msida, MSD 2080, Malta.
Panagiotis AlexiouDepartment of Applied Biomedical Science, Faculty of Health Sciences, University of Malta, Msida, Malta.ORCID 0000-0003-3437-7482

Funding

BioGeMTBioinformatics Core Facility of CEITEC Masaryk University supported by the NCMG Research Infrastructure LM2023067HORIZON-WIDERA-2022 101086768MEYS CRUniversity of Malta, and the e-INFRA CZ project 90254
6 · The paper itself

Abstract

motivationMicroRNAs (miRNAs) regulate gene expression by guiding Argonaute proteins to partially complementary sites on target RNAs. While classical prediction methods rely on engineered features such as seed match categories, evolutionary conservation, and site context, recent advances in deep learning offer the potential to learn targeting rules directly from sequence. We developed a sequence-based deep learning model that improves miRNA target site prediction, and further validated the learned target site representations by extending the model to gene-level functional repression prediction.

resultsWe introduce miRBind2, a deep learning method for miRNA target site prediction that incorporates a novel pairwise nucleotide representation capturing all possible miRNA-target nucleotide interactions, with a CNN-based architecture. miRBind2 outperforms previous SotA models across four independent datasets from the debiased miRBench benchmark, while using 92% fewer parameters. We show that the convolutional features and weights learned by miRBind2 can be transferred to transcript-level prediction by extending the miRBind2 architecture and fine-tuning it on miRNA perturbation experiments. This miRBind2-3UTR model predicts gene repression from sequence alone. On a dataset of 50 549 miRNA-gene pairs, miRBind2-3UTR significantly outperforms TargetScan. These results show that deep models pretrained on target site data can capture regulatory signals and predict functional repression without requiring conventional engineered biological features. AVAILABILITY: Models and source code are freely available via GitHub (https://github.com/BioGeMT/miRBind_2.0). A publicly available web-tool for novel predictions and visualization is available at: (https://huggingface.co/spaces/dimostzim/BioGeMT-miRBind2).

Indexed as

Computational BiologyDeep LearningMicroRNAsSequence Analysis, RNASoftwareBinding SitesMicroRNAs

Identifiers

PMID42635196
PMCPMC13501330

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.